A

Absci

HealthDrug DiscoveryB2B📍 United States

Absci is a drug discovery company that uses AI to develop new medicines. They are focused on automating the drug manufacturing process. This funding round will help them advance their AI-powered drug discovery platform.

Total raised
Undisclosed
tracked to date
Latest round
$75 million
Oct 6, 2026
Known investors
7
led by Deep Insight

Is this your company?

Claim this profile to get matched with investors who fund Health startups in United States.

Claim this profile →

🏆 Featured in Datapile’s Q4 2026 USA Funding Report

Read the Q4 2026 USA report →
Add this badge to your site
<a href="https://datapile.co/reports/q4-2026-usa-startup-funding" target="_blank" rel="noopener" style="display:inline-flex;align-items:center;gap:8px;padding:9px 16px;border-radius:9999px;background:#0B1224;color:#ffffff;font:600 13px/1.2 -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,Arial,sans-serif;text-decoration:none;border:1px solid #7C5CFF"><span style="display:inline-block;width:11px;height:11px;border-radius:3px;background:#7C5CFF"></span>Featured in Datapile&rsquo;s Q4 2026 USA Funding Report</a>

Funding history

  1. 1
    $75 millionOct 6, 2026

    Led by Deep Insight

    Announcement ↗

Investors in Absci

Backers from this company's tracked funding rounds.

Absci in the news

Coverage of this company's funding, tracked by Datapile.

More Health companies

Recently funded startups in the same category.

Related on Datapile